title: [Application of total intravenous anesthesia with remifentanyl and propofol to radiofrequency ablation].
abstract: OBJECTIVE
  Percutaneous radiofrequency ablation (PRFA) is a new and effective microinvasive operation for small hepatocellular carcinoma, but the effect of local anesthesia or single analgesic injection as regular anesthesia is unsatisfied. This study was to evaluate the efficacy and safety of continuous intravenous infusion of remifentanyl combined with propofol as total intravenous anesthesia during PRFA.
  
  
  METHODS
  Sixty patients scheduled for PRFA were randomized into remifentanyl group (R) and fentanyl group (F). Each group contained 30 patients. Group R received remifentanyl infusion at the dose of 0.1 microg x kg(-1) x min(-1) by micro pump; group F received bolus intravenous injection of fentanyl at 1.5 microg x kg(-1) before operation. Anesthesia was maintained with propofol. The mean arterial pressure (MAP), heart rate (HR), pulse oxygen saturation (SPO2), respiration rate (RR), partial pressure of carbon dioxide in artery (PaCO2) and recovery time were measured and recorded by monitor. The limb movement, apnea, body movements, and chest wall rigidity were recorded during operation.
  
  
  RESULTS
  The recovery time of group R was significantly shorter than that of group F [(5.0+/-1.8) min vs. (10.7+/-3.0) min, P<0.001]; the total consumption of propofol was less in group R than in group F [(172.0+/-37.3) mg vs. (330.3+/-61.2) mg, P<0.001]. Group R had less cases with limb movement (5 cases vs. 12 cases) but more cases with apnea (12 cases vs. 6 patients) as compared with group F.
  
  
  CONCLUSIONS
  Total intravenous anesthesia with remifentanyl and propofol for PRFA is safe and reliable. Respiratory depression should be monitored instantly and strictly.
authors.affiliation: State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China. liyi7@mail.sysu.edu.cn
authors.forename: Yi
authors.initials: Y
authors.lastname: Li
authors.forename: Wan
authors.initials: W
authors.lastname: Huang
authors.forename: Yu-Hui
authors.initials: YH
authors.lastname: Long
authors.forename: Wei
authors.initials: W
authors.lastname: Li
authors.forename: Jian
authors.initials: J
authors.lastname: Wang
authors.forename: Min-Shan
authors.initials: MS
authors.lastname: Chen
authors.forename: Mei-Xi
authors.initials: MX
authors.lastname: Xu
mesh_terms: D000762:Anesthesia Recovery Period; D018686:Anesthetics, Intravenous; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology / Q000601:surgery; D017115:Catheter Ablation; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006339:Heart Rate; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008113:Liver Neoplasms / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage*; D015742:Propofol / Q000008:administration & dosage*; D000077208:Remifentanil; D012119:Respiration
chemical_list: D018686:Anesthetics, Intravenous; D010880:Piperidines; D002245:Carbon Dioxide; D000077208:Remifentanil; D005283:Fentanyl; D015742:Propofol